These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 19416677)

  • 1. The Alzheimer's disease mitochondrial cascade hypothesis: an update.
    Swerdlow RH; Khan SM
    Exp Neurol; 2009 Aug; 218(2):308-15. PubMed ID: 19416677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Alzheimer's disease mitochondrial cascade hypothesis.
    Swerdlow RH; Burns JM; Khan SM
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S265-79. PubMed ID: 20442494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.
    Swerdlow RH; Burns JM; Khan SM
    Biochim Biophys Acta; 2014 Aug; 1842(8):1219-31. PubMed ID: 24071439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the cause of sporadic Alzheimer's disease.
    Zetterberg H; Mattsson N
    Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.
    Kopeikina KJ; Carlson GA; Pitstick R; Ludvigson AE; Peters A; Luebke JI; Koffie RM; Frosch MP; Hyman BT; Spires-Jones TL
    Am J Pathol; 2011 Oct; 179(4):2071-82. PubMed ID: 21854751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease.
    Kim DK; Mook-Jung I
    BMB Rep; 2019 Dec; 52(12):679-688. PubMed ID: 31722781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
    Swerdlow RH; Khan SM
    Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial links between brain aging and Alzheimer's disease.
    Wilkins HM; Swerdlow RH
    Transl Neurodegener; 2021 Sep; 10(1):33. PubMed ID: 34465385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria, Cybrids, Aging, and Alzheimer's Disease.
    Swerdlow RH; Koppel S; Weidling I; Hayley C; Ji Y; Wilkins HM
    Prog Mol Biol Transl Sci; 2017; 146():259-302. PubMed ID: 28253988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging-Dependent Mitophagy Dysfunction in Alzheimer's Disease.
    Song M; Zhao X; Song F
    Mol Neurobiol; 2021 May; 58(5):2362-2378. PubMed ID: 33417222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.
    Swerdlow RH
    Antioxid Redox Signal; 2012 Jun; 16(12):1434-55. PubMed ID: 21902597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria: the common upstream driver of amyloid-β and tau pathology in Alzheimer's disease.
    Silva DF; Esteves AR; Oliveira CR; Cardoso SM
    Curr Alzheimer Res; 2011 Aug; 8(5):563-72. PubMed ID: 21244356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.
    Rai SN; Singh C; Singh A; Singh MP; Singh BK
    Mol Neurobiol; 2020 Jul; 57(7):3075-3088. PubMed ID: 32462551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
    Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
    Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease.
    Cabezas-Opazo FA; Vergara-Pulgar K; Pérez MJ; Jara C; Osorio-Fuentealba C; Quintanilla RA
    Oxid Med Cell Longev; 2015; 2015():509654. PubMed ID: 26221414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease.
    Orsucci D; Mancuso M; Ienco EC; Simoncini C; Siciliano G; Bonuccelli U
    Curr Neurovasc Res; 2013 Feb; 10(1):76-80. PubMed ID: 23151073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection.
    Quntanilla RA; Tapia-Monsalves C
    Curr Neuropharmacol; 2020; 18(11):1076-1091. PubMed ID: 32448104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer's disease.
    Medala VK; Gollapelli B; Dewanjee S; Ogunmokun G; Kandimalla R; Vallamkondu J
    J Neurosci Res; 2021 Apr; 99(4):1120-1135. PubMed ID: 33465841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.